JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13

Benzinga · 1d ago
JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $9 to $13.